Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood

INTRODUCTION: We examined longitudinal cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarker changes among cognitively normal individuals with 10.7 years follow‐up, on average. METHODS: Analyses included 278 participants (M age = 57.5 years); 94 have progressed from normal cognition to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettigrew, Corinne, Soldan, Anja, Wang, Jiangxia, Wang, Mei‐Cheng, Greenberg, Barry, Albert, Marilyn, Moghekar, Abhay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673459/
https://www.ncbi.nlm.nih.gov/pubmed/36415591
http://dx.doi.org/10.1002/dad2.12374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673459/
https://www.ncbi.nlm.nih.gov/pubmed/36415591
http://dx.doi.org/10.1002/dad2.12374

Ejemplares similares